Universitätsklinikum Carl Gustav Carus Dresden


Location: Dresden, Germany (DE) DE

ISNI: 0000000110912917

ROR: https://ror.org/04za5zm41

Show on Map:


Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year




Effectiveness of IT-supported patient recruitment: study protocol for an interrupted time series study at ten German university hospitals (2024) Boeker M, Zöller D, Blasini R, Macho P, Helfer S, Behrens M, Prokosch HU, Gulden C Journal article Multicenter evaluation of complex urinary diversion for renal transplantation: outcomes of complex surgical solutions (2024) Flegar L, Huber J, Putz J, Thomas C, Apel H, Wullich B, Friedersdorff F, et al. Journal article NRN1 interacts with Notch to increase oncogenic STAT3 signaling in melanoma (2024) Devitt L, Westphal D, Pieger K, Schneider N, Boßerhoff AK, Kuphal S Journal article DNA methylation episignature and comparative epigenomic profiling for Pitt-Hopkins syndrome caused by TCF4 variants (2024) van der Laan L, Lauffer P, Rooney K, Silva A, Haghshenas S, Relator R, Levy MA, et al. Journal article Impact of Vaccination Status on Outcome of Patients With COVID-19 and Acute Ischemic Stroke Undergoing Mechanical Thrombectomy (2024) Deuschl C, Goertz L, Kabbasch C, Köhrmann M, Kleinschnitz C, Berlis A, Maurer CJ, et al. Journal article Sun protection in outdoor workers – Development and validation of standardized questionnaires for behavior and knowledge (2024) Rönsch H, Rocholl M, Ludewig M, Staudt A, Langner M, Steeb T, Wilke A, et al. Journal article, Original article recruIT: A cloud-native clinical trial recruitment support system based on Health Level 7 Fast Healthcare Interoperability Resources (HL7 FHIR) and the Observational Medical Outcomes Partnership Common Data Model (OMOP CDM) (2024) Gulden C, Macho P, Reinecke I, Strantz C, Prokosch HU, Blasini R Journal article Second-line therapies for steroid-refractory immune-related adverse events in patients treated with immune checkpoint inhibitors (2024) Ruf T, Kramer R, Forschner A, Leiter U, Meier F, Reinhardt L, Dücker P, et al. Journal article Long-term outcomes of a randomized, open-label, phase II study comparing cabazitaxel versus paclitaxel as neoadjuvant treatment in patients with triple-negative or luminal B/HER2-negative breast cancer (GENEVIEVE) (2024) Meyer-Wilmes P, Huober J, Untch M, Blohmer JU, Janni W, Denkert C, Klare P, et al. Journal article Susceptibility of Melanoma Cells to Targeted Therapy Correlates with Protection by Blood Neutrophils (2024) Wendlinger S, Wohlfarth J, Siedel C, Kreft S, Kilian T, Junker S, Schmid L, et al. Journal article